Cushing Triad, also known as the Cushing reflex, is a medical condition characterized by a combination of three signs: hypertension, bradycardia, and an irregular respiratory rate. It is most commonly associated with increased intracranial pressure (ICP) due to a variety of causes, including traumatic brain injury, brain tumors, hydrocephalus, and intracranial hematomas. The triad is named after Harvey Cushing, an American neurosurgeon who first described the condition in 1932. This article provides a comprehensive overview of Cushing Triad, including its diagnosis and treatment.
The diagnosis of Cushing Triad is based on the presence of three clinical signs: hypertension, bradycardia, and an irregular respiratory rate. Hypertension is defined as a systolic blood pressure greater than 150 mmHg and/or a diastolic blood pressure greater than 90 mmHg. Bradycardia is defined as a heart rate less than 60 beats per minute. An irregular respiratory rate is defined as an increase in the respiratory rate of more than 10 breaths per minute or a decrease in the respiratory rate of more than 10 breaths per minute. The diagnosis of Cushing Triad is usually made based on the presence of these three clinical signs. However, in some cases, additional tests may be necessary to confirm the diagnosis. These tests may include computed tomography (CT) or magnetic resonance imaging (MRI) scans of the head, a lumbar puncture to measure the intracranial pressure, and/or an electroencephalogram (EEG) to measure brain activity.
Cushing Triad is most commonly associated with increased intracranial pressure (ICP) due to a variety of causes, including traumatic brain injury, brain tumors, hydrocephalus, and intracranial hematomas. Other causes of Cushing Triad include meningitis, subarachnoid hemorrhage, and intracranial hypertension due to drug toxicity or metabolic disorders.
The treatment of Cushing Triad is aimed at reducing the underlying cause of the increased intracranial pressure. This may include surgery to remove the tumor or hematoma, or to relieve pressure on the brain. Other treatments may include medications to reduce the pressure, such as diuretics, corticosteroids, and osmotic agents. In some cases, treatment may also include the use of a ventriculostomy, which is a procedure in which a small hole is made in the skull to relieve pressure on the brain. Finally, in some cases, treatment may include the use of a shunt, which is a device that is surgically implanted to divert excess cerebrospinal fluid away from the brain.
Cushing Triad is a medical condition characterized by a combination of three signs: hypertension, bradycardia, and an irregular respiratory rate. It is most commonly associated with increased intracranial pressure due to a variety of causes, including traumatic brain injury, brain tumors, hydrocephalus, and intracranial hematomas. The diagnosis of Cushing Triad is based on the presence of these three clinical signs, and additional tests may be necessary to confirm the diagnosis. Treatment of Cushing Triad is aimed at reducing the underlying cause of the increased intracranial pressure, and may include surgery, medications, a ventriculostomy, or a shunt.
1.
According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.
2.
Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness
3.
Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer
4.
According to a study, taking part in a clinical trial for cancer may not actually increase survival.
5.
A new blood test greatly increases the ability to detect cancer.
1.
Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis
2.
Unraveling the Mysteries of Hematocrit: How It Impacts Your Health
3.
The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers
4.
Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer
5.
Surprising Symptoms of Prostate Cancer: What You Need to Know
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part X
2.
Efficient Management of First line ALK-rearranged NSCLC - Part III
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
5.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation